Business

Eli Lilly blows past estimates, hikes guidance as Zepbound, Mounjaro sales soar

The success of Eli Lilly's weight loss and diabetes drugs Zepbound and Mounjaro caused the company to hike its guidance.

adminadmin
Aug 9, 2024 - 03:00
 0  7
Eli Lilly blows past estimates, hikes guidance as Zepbound, Mounjaro sales soar
The success of Eli Lilly's weight loss and diabetes drugs Zepbound and Mounjaro caused the company to hike its guidance.
Read More

Tags:

Previous Article

Boeing's new outsider CEO Ortberg takes the helm, this time from the factory floor

Next Article

Restaurant Brands revenue tops estimates, fueled by Tim Hortons

admin
admin

Related Posts

UAW union endorses Vice President Kamala Harris for president over Trump

UAW union endorses Vice President Kamala Harris for pre...

admin Aug 1, 2024  0  13

FDA approval of Eli Lilly's Alzheimer's drug cements our decision not to take profits

FDA approval of Eli Lilly's Alzheimer's drug cements ou...

admin Jul 3, 2024  0  7

UK economy surprises with September contraction, grows just 0.1% in the third quarter

UK economy surprises with September contraction, grows ...

admin Nov 15, 2024  0  4